Panacos Pharmaceuticals is a biotechnology company founded in 1999 that focuses on developing innovative small-molecule oral drugs to combat HIV and other viral diseases. The company's research emphasizes unique targets in the virus life cycle, including maturation and fusion of the virus. With a product pipeline consisting of both second- and third-generation programs in HIV maturation inhibition, Panacos Pharmaceuticals is at the forefront of creating advanced solutions in the fight against HIV. Their latest investment of $20.00M in post-IPO debt was made on 28 June 2007 by Hercules Capital. Based in Watertown, Massachusetts, the company continues to make significant strides in the biotechnology, healthcare, and medical devices industries.
Panacos Pharmaceuticals
Innovative solutions in the fight against HIV and other viral diseases using advanced small-molecule oral drugs
General Information
BounceWatch is an independent company data service, not affiliated with Panacos Pharmaceuticals. To contact Panacos Pharmaceuticals, visit panacos.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Panacos Pharmaceuticals compare?
A PDF of Panacos Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Panacos Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Panacos Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Panacos Pharmaceuticals
Business keywords: Drug Discovery, Small-Molecule Drugs, Oral Drugs, Viral Diseases Treatment, HIV Treatment, Virus Life Cycle, Maturation Inhibition, Fusion Inhibition, Pharmaceutical Research, Innovative Drugs, HIV Research, Biotech Startups, Healthcare Innovation, Medical Technology
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $20.00M | 1 |
|
28 Jun 2007 |
| Post IPO Equity | $20.00M | 1 |
|
10 Dec 2004 |
| Post IPO Equity | $18.30M | 8 |
|
18 May 2004 |
Panacos Pharmaceuticals Alternatives & Competitors
View All Alternatives
Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a stron...
Innovating patient care with advanced small molecule therapies for severe medical conditions, includ...
Pioneering innovative treatments in oncology and beyond through a robust Hsp90 inhibitor platform an...
Cidara Therapeutics
FAQ About Panacos Pharmaceuticals
Source: BounceWatch company record for Panacos Pharmaceuticals, https://bouncewatch.com/company/panacos-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.
